SOURCE: IO NewsWire

IO NewsWire

September 21, 2010 07:30 ET

(OTC: APDN) Patented Product Aims at Reducing Counterfeit Goods

NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by the IO News Wire.

NEW YORK, NY--(Marketwire - September 21, 2010) -  Applied DNA Sciences, Inc. (OTCBB: APDN), a leader in the protection of products, brands and intellectual property from counterfeiting and diversion, has recently announced several key developments across the globe that will help grow their core business in the coming years.

The World Customs Organization estimated annual global trade in illegitimate goods at about $600 billion (2004), which is expected to double to $1.2 trillion by 2014, representing 5% to 7% of all worldwide trade. Applied DNA Sciences is the only company in the world that is currently applying complex embedded botanical DNA for use in the authentication of everything from currency to wines and spirits. 

SigNature DNA, Applied Sciences patented authentication product, has less than a 1 in a trillion error frequency which will help ensure its global acceptance as nearly irrefutable evidence when validating a products authenticity.

For more information please visit www.proactivenewsroom.com/apdn

Other active stocks are Smart Holdings, Inc (PINKSHEETS: SMHS) Diebold Inc (NYSE: DBD) and Nu Horizons Electronics Corp (NASDAQ: NUHC)

Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A third party has hired and paid IO News Wire twelve hundred and ninety five dollars for the publication and circulation of this news release. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation; do no trading of any kind and send no faxes or emails.

Contact Information